# Pyrazinamide

## Pyrazinamide 500mg

| 藥物代碼 | OPYRZ |
| :--- | :--- |
| 適應症 | Treatment of pulmonary & extrapulmonary TB. |
| 副作用 | Hepatotoxicity, jaundice, hyperuricemia leading to attacks of gout, anorexia, nausea, vomiting, arthralgia, malaise, fever, sideroblastic anemia, difficulty in micturition.Endocrine metabolic: HyperuricemiaGastrointestinal: Nausea, VomitingMusculoskeletal: Arthralgia \(40%\) |
| 禁忌 | Hypersensitivity to pyrazinamide or any component of the formulation; acute gout; severe hepatic damage |
| 藥物保存方式 | 25度C以下 |
| 用法用量 | Always administer in combination with other antitubercular drugs. 20-35 mg/kg daily in 3-4 divided doses. \(max. 3 gm/day\). |
| 肝功能異常 | 無需調整劑量 |
| 腎功能異常 | 需 調 整 劑 量 |
| 懷孕用藥危分級 | 除非治療上需要 |
| 孕期用藥建議 | Compatible - maternal benefit &gt;&gt; embryo-fetal risk |
| 附帶說明 | PREGNANCY RECOMMENDATION: Compatible—Maternal Benefit &gt;&gt; Embryo–Fetal Risk |
| 哺乳期用藥建議 | No \(Limited\) Human Data - Probably Compatible 無\(很少\)資料 - 可使用 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | AC, AC15, PO, WM |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | N/A |

